Global Insights on Repeated Low-Level Red-Light Therapy for Myopia
Provider: Mivision
Activity Outline
In recent years, a multitude of journals have published articles on the use of repeated low-level red-light therapy (RLRL) to manage myopia. Dr Kate Gifford, founder of Myopia Profile and guest editor of this issue of mivision, recently interviewed three distinguished experts of ophthalmology and optometry – Professor Andrzej Grzybowski from Poland, Professor Kyoko Ohno-Matsui from Japan, and Dr Nellie Deen from Australia – to find out about their research and real-world use of RLRL for myopia management in children. Dr Yuri Aung from Eyerising International, manufacturer of the RLRL myopia device, summarises the conversations.
Learning Objectives
- Better understand the potential role repeated low-level red-light (RLRL) therapy plays in myopia control
- Be aware of clinical trials underway that are assessing safety and efficacy of RLRL
- Recognise the patients most likely to benefit from RLRL
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| Global Insights on Repeated Low-Level Red-Light Therapy for Myopia |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |